HI,欢迎来到学术之家,发表咨询:400-888-7501  订阅咨询:400-888-7502  股权代码  102064
0

S3A-4 Inhibition of Phosphodiesterase 4 by FCPR16 Protects SH-SY5Y Cells against MPP^+-Induced Cell Death through Activating cAMP/PKA/CREB and Epac/Akt Signaling Pathways

作者:ZHONG; Jia-hong; WANG; Hai-tao; XU; Ji...phosphodiesterase4fcpr16oxidativestressmitochondrialmembranepotentialdisease

摘要:Background:Phosphodiesterase 4(PDE4)is a promising target for the treatment of Parkinson’s disease(PD).However,the underlying mechanism has not yet been well elucidated.Additionally,most of current PDE4 inhibitors produce severe nausea and vomiting response in patients,which limit their clinical application.FCPR16 is a novel PDE4 inhibitor with little emetic potential.In the present study,the neuroprotective effect and underlying mechanism of FCPR16 against cellular apoptosis induced by 1-methyl-4-phenylpyridinium(MPP+)were examined in SH-SY5Y cells and primary cultured neurons.Methods:CCK-8 assay,Hoechst staining,lactate dehydrogenase release and flow cytometry were used to study the protective effect of FCPR16 against cell damage caused by MPP+.Mitochondrial membrane potential(Δψm)was measured by JC-1 staining.The extent of oxidation was evaluated using Cell ROXs Deep Red Reagent and malonaldehyde(MDA)kit.Pretreatments with various pathway inhibitors were used to investigate the possible pathways involved in the protection of FCPR16.The phosphorylated and total levels of various proteins were analyzed by Western blot.Results:FCPR16(12.5-50μmol·L-1)dose-dependently reduced MPP+-induced loss of cell viability,accompanied by reductions in nuclear condensation and lactate dehydrogenase release.The level of cleaved caspase 3 and the ratio of Bax/Bcl-2 were also decreased after treatment with FCPR16 in MPP+-treated cells.Furthermore,FCPR16(25μmol·L-1)significantly suppressed the accumulation of reactive oxygen species(ROS),prevented the decline ofΔψm and attenuated the expression of MDA level.Further studies disclosed that FCPR16 enhanced the levels of cAMP and the exchange protein directly activated by cAMP(Epac)in SH-SY5Y cells.Western blotting analysis revealed that FCPR16 increased the phosphorylation of cAMP response element-binding protein(CREB)and protein kinase B(Akt)down-regulated by MPP+in SH-SY5Y cells.Moreover,the inhibitory effects of FCPR16 on the production of ROS andΔψm loss could be block

注:因版权方要求,不能公开全文,如需全文,请咨询杂志社

神经药理学报

《神经药理学报》(CN:13-1361/R)是一本有较高学术价值的大型双月刊,自创刊以来,选题新奇而不失报道广度,服务大众而不失理论高度。颇受业界和广大读者的关注和好评。 《神经药理学报》内容涉及神经解剖学、神经生物学、神经生理学等领域,报道与神经系统疾病发病机制及其治疗相关的中药有效成分、天然药物化学、药物分析学、分子生物学、药剂学及毒理学方面的研究论著,具有前沿性、创新性、科学性、实用性的特点,及时、快速反映神经药理学最新科研成果和研究进展。

杂志详情